Adhere+
Adhere+ provides a Remote Therapeutic Monitoring platform that enables U.S. healthcare providers in pain management, bariatrics, and chronic disease care to automate documentation, track patient-reported outcomes, and bill CMS CPT reimbursement codes for patient engagement.
- Company typePrivate
- Founded2020
- HeadquartersWashington, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Adhere+ does
Adhere+ (legal entity AdherePlus, Inc., Delaware-incorporated; Washington, DC headquarters) sells a Remote Therapeutic Monitoring (RTM) platform targeted at U.S. healthcare providers, with a primary focus on pain management and secondary specialties including bariatrics and broader chronic disease care. The platform is built on physician-crafted RTM protocols and the proprietary AARC Framework, which automates audit-ready documentation to reduce the administrative load of CMS-compliant record keeping; it captures Electronic Patient-Reported Outcomes (ePROs) and supports remote patient interactions between visits. Management cites 5 million ePROs tracked, 1.2 million RTM patient interactions, and 8 NIH/NIMH studies as scale and validation evidence, alongside a third-party study covering 844,000+ patients across 40 clinics showing improvements in anxiety, depression, and pain symptoms.
The commercial model is a subscription/recurring SaaS, but it is monetized through CMS-adopted AMA CPT RTM reimbursement codes, allowing practices to bill for previously uncompensated activities such as patient phone calls, emails, and clinical follow-ups. Adhere+ sells directly to practices via a sales-led motion, and in October 2025 launched a Flagship Office initiative with Pain Consultants of East Tennessee designed to generate real-world data supporting replication to other practices and regions. The company publicly discloses no pricing tiers, ARR, or revenue; it filed an SEC Form D in February 2026 for a Rule 506(b) exempt offering seeking up to $15,000,000.
The leadership team is positioned for commercialization: CEO Jim Bridenstein (prior exits including Kyphon at $4.2B and PEAR Therapeutics), President/Co-Founder Dan Cohen (FDA approvals including Apadaz, VBLOC, and Juvederm), CFO Andy Plummer (grew Thomson Reuters Special Services to $130M), CTO Scott Cashon, CMO Emeritus Dr. Lynn Webster (past president of AAPM, 300+ publications), and VP Marketing Jeff Huynh. Operations are U.S.-only, headcount is stated at 11-50, and the company is privately held with no public ticker.
Adhere+ firmographics
Firmographics- Name
- Adhere+
- Legal name
- AdherePlus, Inc.
- Website
- https://adhereplus.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Adhere+ provides a Remote Therapeutic Monitoring platform that enables U.S. healthcare providers in pain management, bariatrics, and chronic disease care to automate documentation, track patient-reported outcomes, and bill CMS CPT reimbursement codes for patient engagement.
- Ownership category
- akta.pro rank
Adhere+ industry classification
Industry- Product category
- Remote Therapeutic Monitoring Software
- NAICS
- Home Health Care Services (62161), Offices of Physicians (6211), Services for the Elderly and Persons with Disabilities (624120)
- SIC
- Services-Health Services (8000), Services-Home Health Care Services (8082), Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Remote Therapeutic Monitoring (RTM) & Digital Rehabilitation Platforms (HLALABAK)
- akta.pro secondary industries
- Adherence, Reminders & Engagement Automation (Medication/Follow-up) (HLACAEAJ), Care Pathway Automation & Patient Engagement for RPM (Coaching, Messaging, Scheduling) (HLACAPAM), Patient Engagement, Education & Messaging Platforms (portal/CRM integrated) (HLALABAJ)
Keywords
Where Adhere+ is headquartered
LocationHeadquarters
- HQ city
- Washington
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Adhere+ business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- RTM Reimbursement Services: CMS-adopted AMA CPT codes reimburse RTM services, allowing practices to monetize difficult-to-capture efforts like patient phone calls, emails, and clinical follow-ups. This creates a financially sustainable model for healthcare providers while enabling enhanced care delivery.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Adhere+ product offering
Product offeringCore offering
Adhere+ provides a research-founded Remote Therapeutic Monitoring (RTM) platform that enables healthcare providers in specialties such as pain management, bariatrics, and chronic disease care to remotely monitor patients, collect electronic Patient-Reported Outcomes (ePROs), and automate audit-ready documentation via the proprietary AARC Framework. The platform is designed to help practices capture reimbursement through CMS-adopted AMA CPT codes for previously uncompensated patient follow-ups such as phone calls, emails, and clinical outreach.
Product overview
Adhere+ offers a single unified Remote Therapeutic Monitoring platform called the Adhere+ RTM Platform. The platform centers on electronic Patient-Reported Outcomes (ePROs) and real-time RTM patient interactions, enabling providers to monitor patients remotely and generate actionable insights. The platform is enhanced by the proprietary AARC Framework which automates documentation to streamline regulatory compliance. It serves multiple specialties including pain management, bariatrics, and chronic disease care, and integrates directly with AMA CPT codes for RTM reimbursement.
Differentiator
Problem solved
Functional benefit
Quantifiable outcome
- Significant improvements in anxiety, depression, and pain symptoms across 844,000+ patients in 40 clinics
- +2 more outcomes
Companies that use Adhere+
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles3 records
Adhere+ technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Adhere+ partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Pain Consultants of East TennesseeflagshipA partnership launching Pain Consultants of East Tennessee as the initial Flagship Office to demonstrate how remote therapeutic monitoring (RTM) can improve chronic pain management and patient outcomes. The initiative aims to generate real-world data to support scaling RTM across other practices and regions, particularly in high-need, reimbursement-challenged environments.
Scale indicators5 records
Recent moves5 records
Expansion highlights5 records
Adhere+ competitors and assessment
Company assessmentDirect peers
- Health Recovery Solutions (HRS): Well-established RPM platform provider serving hospitals, health systems, and physician practices with connected care solutions—a more mature, broader competitor with overlapping customer base.
- Prevounce Health: A direct RTM-focused competitor offering remote patient monitoring and chronic care management platforms specifically designed to help physician practices capture CMS RTM reimbursement—virtually identical value proposition to Adhere+.
- CoachCare: Provides remote patient monitoring, chronic care management, and RTM software to medical practices, with a similar sales-led GTM targeting specialty providers and reimbursement capture.
- Medsien: Specializes in Remote Therapeutic Monitoring and Chronic Care Management services for physician practices, targeting similar specialty providers and reimbursement-driven workflows as Adhere+.
Broad incumbents
- Omada Health: Established digital therapeutics and chronic disease management platform addressing diabetes, hypertension, and behavioral health—adjacent competitor with overlapping chronic care patient population.
- Vivify Health: A larger, established RPM and virtual care platform serving health systems and payers with broader remote monitoring capabilities that overlap Adhere+'s RTM offering.
Emerging players
- Biofourmis: AI-powered RPM platform with predictive analytics for chronic disease management, targeting similar provider and pharma customers with a more technology-forward approach than Adhere+.
- Welldoc: Digital health company focused on chronic condition management (diabetes, cardiovascular) with FDA-cleared platforms—competes in adjacent RTM-adjacent reimbursement-driven workflows.
- Athelas: A well-funded, fast-growing remote patient monitoring and ambient AI company serving physician practices with overlapping chronic care and reimbursement-driven workflows.
Others
- Somryst (Pear Therapeutics successor assets): Digital therapeutic platforms for chronic conditions including pain management—directly relevant as Adhere+'s CEO previously led PEAR Therapeutics, the world's first PDT, indicating prior domain overlap.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Adhere+ social profiles
Digital presenceAdhere+ financial estimates
Financial estimateRevenue estimate
Valuation estimate
Adhere+ leadership team
Management profileNumber of profiles
Profiles7 records
Adhere+ funding detail
Funding detailFunding overview
Funding rounds2 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Adhere+ M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Adhere+
What does Adhere+ do?
Adhere+ provides a research-founded Remote Therapeutic Monitoring (RTM) platform that enables healthcare providers in specialties such as pain management, bariatrics, and chronic disease care to remotely monitor patients, collect electronic Patient-Reported Outcomes (ePROs), and automate audit-ready documentation via the proprietary AARC Framework. The platform is designed to help practices capture reimbursement through CMS-adopted AMA CPT codes for previously uncompensated patient follow-ups such as phone calls, emails, and clinical outreach.
Is Adhere+ a public or private company?
Adhere+ is a private company. It is classified as unknown and is currently operating.
When was Adhere+ founded?
Adhere+ was founded in 2020. It employs 11 to 50 people.
Where is Adhere+ based?
Adhere+ is headquartered in Washington, United States, in the North America region.
How does Adhere+ make money?
One revenue line is on record: RTM Reimbursement Services.
Who are Adhere+'s main competitors?
Direct peers on record are Health Recovery Solutions (HRS), Prevounce Health, CoachCare and Medsien. Broad incumbents are Omada Health and Vivify Health. Emerging players are Biofourmis, Welldoc and Athelas. Somryst (Pear Therapeutics successor assets) is listed as an others.
Does Adhere+ have an API?
No public API is recorded for Adhere+.
What industry is Adhere+ in?
Adhere+'s product category is Remote Therapeutic Monitoring Software. Its primary akta.pro industry code is HLALABAK, Remote Therapeutic Monitoring (RTM) & Digital Rehabilitation Platforms, with a secondary code of HLACAEAJ, Adherence, Reminders & Engagement Automation (Medication/Follow-up). Its NAICS code is 62161 and its SIC code is 8000.